Sector revisions Indivior Pharmaceuticals, Inc. London S.E.
Equities
INDV
US45579U1097
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
-.--% | - |
| 01-26 | Indivior Pharmaceuticals Completes Redomiciliation to US From UK | MT |
| 01-08 | Indivior PLC Provides Earnings Guidance for the Full Year 2026 | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 16 | |||||||
| 8 | |||||||
| 11 | |||||||
| 14 | |||||||
| 19 | |||||||
| 6 | |||||||
| 2 | |||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| 2 | |||||||
| 5 | |||||||
| - | 1 | ||||||
| 13 | |||||||
| Average | 9 | |||||||
| Weighted average by Cap. | 14 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition